{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed\/Refractory Multiple Myeloma (CaMMouflage Trial)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-multicenter-open-label-study-of-cb-011-a-crispr-edited-allogeneic-anti-bcma-car-t-cell-therapy-in-patients-with-relapsed-refractory-multiple-myeloma-cammouflage-trial\/#breadcrumbitem"}]}